期刊文献+

血清CA125浓度与肝硬化患者腹水量关系的临床研究 被引量:3

下载PDF
导出
摘要 癌抗原125(CA125)是一种大分子聚合糖蛋白,主要存在于卵巢肿瘤的上皮细胞内,用于卵巢癌的诊断和疗效观察,但近年来一些研究表明,
出处 《中国现代医药杂志》 2009年第9期86-87,共2页 Modern Medicine Journal of China
  • 相关文献

参考文献11

二级参考文献18

  • 1冷爱民,张桂英.CA125在肝硬化患者中的前瞻性观察[J].世界华人消化杂志,2004,12(7):1759-1760. 被引量:14
  • 2吴丛山,刘徐桂.CA199、CA125、CEA联检对胰腺癌诊断价值的评价[J].放射免疫学杂志,2005,18(6):505-507. 被引量:3
  • 3田怡,付极,刘建生.肝硬化失代偿期血清CA 125的变化[J].临床消化病杂志,2006,18(1):52-53. 被引量:6
  • 4王琳,滕佩红,姜丽华,张乐研,杨晓平.卵巢肿瘤患者血清CA125、CA199及其联检的临床意义[J].放射免疫学杂志,2006,19(1):58-58. 被引量:3
  • 5Friedlander ML.Prognostic factors in ovarian cancer.Semin Oncol.1998,25:305.
  • 6Gadducci A,Ferdeghini M,Pronteva C,et al.The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses:Relevance for differential diagnosis.Gyncol.1992,44:147.
  • 7叶任高,陆再英.内科学[M].第6版.北京:人民卫生出版社,2006:787.
  • 8Pina TC,Zapata IT,Lopez JB,et al.Tumor markers in lung cancer:does the method of obtaining the cut-off point and reference population influence diagnostic yield[J].Clin Bio Chem,1999,32(6):467-472.
  • 9Ando S,Kimura H,Iwai N,et al.Optimal combination of seven tumor markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer[J].Anticancer Res,2001,21(46):3085-3092.
  • 10Pollan M,Varela G,Torres A,et al.Clinical value of p53,c-erbB-2,CEA and CA125 regarding relapse,metastasis and death in resectable non-small cell lung cancer[J].Int J Cancer,2003,107(5):781-790.

共引文献87

同被引文献24

  • 1Joshua G Cohen,Matthew White,Ana Cruz,Robin Farias-Eisner.WJBC 5^(th) Anniversary Special Issues(2): Proteomics In 2014, can we do better than CA125 in the early detection of ovarian cancer?[J].World Journal of Biological Chemistry,2014,5(3):286-300. 被引量:18
  • 2Collazos J,Genolla,Ruibal A.CA125 levels in patients with non-neoplastic liver diseases,a clinical and laboratory study[J].Scan J Clin Lab Invest,1992,52(3):201 -206.
  • 3Kovasc EJ,Messingham KA.Influence of alcohol and gender on immune response[J].Alcohol Res Health,2002,26 (4):257 - 263.
  • 4Pauler DK,Menon U,Mcintosh M,et al.Factors influencing serum CA125 Ⅱ levels in healthy postmenopausal women[J].Cancer Epidemiol Biomarkers Prev,2001,10(5):489-493.
  • 5Sch(o)niger-Hekele Maximilian,Müller C.The combined elevation of tumor markers CA 19-9 and CA125 in liver disease patients is highly specific for severe liver fibrosis[J].Dig Dis Sci,2006,51 (2):338 -345.
  • 6Kalambokis G,Kostoula A,Economou M,et al.Tumor necrosis factoralpha-related intraperitoneal release of CA125 in cirrhotic patients with sterile ascites[J].Clin Chem,2005,51 (11):2207 - 2208.
  • 7陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 8中华医学会肝病学会,中华医学会感染病学会.慢性乙型肝炎防治指南(2010年版)[J].中华肝胆病杂志(电子版),2011,3(1):40-55.
  • 9吴冬寒,麦子青.CA125在肝硬化腹水中的诊断价值[J].山东医药,2008,48(14):140-141. 被引量:5
  • 10沈菁,徐如梅,吴绍莲,韦常宏.探讨肿瘤标记物CEA、CA15-3、CA19-9、CA125及AFP在胸腔积液中的诊断价值[J].实验与检验医学,2009,27(1):39-41. 被引量:10

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部